Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
Wong CK, French JK, Aylward PE, Stewart RA, Gao W, Armstrong PW, Van De Werf FJ, Simes RJ, Raffel OC, Granger CB, Califf RM, White HD; HERO-2 Trial Investigators. Wong CK, et al. Among authors: simes rj. J Am Coll Cardiol. 2005 Jul 5;46(1):29-38. doi: 10.1016/j.jacc.2005.02.084. J Am Coll Cardiol. 2005. PMID: 15992631 Free article.
Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques.
Edmond JJ, French JK, Stewart RA, Aylward PA, De Pasquale CG, Williams BF, O'Connell RL, Simes RJ, White HD; HERO-2 Investigators. Edmond JJ, et al. Among authors: simes rj. Am J Cardiol. 2006 Apr 1;97(7):947-51. doi: 10.1016/j.amjcard.2005.10.031. Epub 2006 Feb 13. Am J Cardiol. 2006. PMID: 16563892
White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
Stewart RA, White HD, Kirby AC, Heritier SR, Simes RJ, Nestel PJ, West MJ, Colquhoun DM, Tonkin AM; Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Investigators. Stewart RA, et al. Among authors: simes rj. Circulation. 2005 Apr 12;111(14):1756-62. doi: 10.1161/01.CIR.0000160924.73417.26. Epub 2005 Apr 4. Circulation. 2005. PMID: 15809366 Clinical Trial.
Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
Simes RJ, O'Connell RL, Aylward PE, Varshavsky S, Diaz R, Wilcox RG, Armstrong PW, Granger CB, French JK, Van de Werf F, Marschner IC, Califf R, White HD; HERO-2 Investigators. Simes RJ, et al. Am Heart J. 2010 Jun;159(6):988-97. doi: 10.1016/j.ahj.2009.12.044. Am Heart J. 2010. PMID: 20569711 Clinical Trial.
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
Al-Khatib SM, Granger CB, Huang Y, Lee KL, Califf RM, Simoons ML, Armstrong PW, Van de Werf F, White HD, Simes RJ, Moliterno DJ, Topol EJ, Harrington RA. Al-Khatib SM, et al. Among authors: simes rj. Circulation. 2002 Jul 16;106(3):309-12. doi: 10.1161/01.cir.0000022692.49934.e3. Circulation. 2002. PMID: 12119245
Depression and cardiovascular morbidity and mortality: cause or consequence?
Stewart RA, North FM, West TM, Sharples KJ, Simes RJ, Colquhoun DM, White HD, Tonkin AM; Long-Term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study Investigators. Stewart RA, et al. Among authors: simes rj. Eur Heart J. 2003 Nov;24(22):2027-37. doi: 10.1016/j.ehj.2003.08.017. Eur Heart J. 2003. PMID: 14613739 Clinical Trial.
Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.
Stewart RA, North FM, Sharples KJ, Simes RJ, Tonkin AM, White HD; Long-term Intervention with Pravastatin in Ischaemic Disease Study Investigators. Stewart RA, et al. Among authors: simes rj. N Z Med J. 2008 Feb 15;121(1269):11-23. N Z Med J. 2008. PMID: 18278078
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.
West M, Kirby A, Stewart RA, Blankenberg S, Sullivan D, White HD, Hunt D, Marschner I, Janus E, Kritharides L, Watts GF, Simes J, Tonkin AM; LIPID Study Group *. West M, et al. J Am Heart Assoc. 2022 Mar;11(5):e020745. doi: 10.1161/JAHA.121.020745. Epub 2022 Feb 18. J Am Heart Assoc. 2022. PMID: 35179040 Free PMC article.
207 results